All Insights
Future Planet invests in Vaccitech’s $168M Series B
London, UK – 17th March 2021: Future Planet Capital has invested in a…
Vaccitech raises $168M Series B to progress three Phase 2 trials
Oxford, UK – Vaccitech Ltd (“Vaccitech”), a clinical-stage biopharmaceutical company engaged in the discovery…
Future Planet backs Oxford Vaccine Company
“A biotechnology company whose research and intellectual property has helped to create the…
Vaccitech, Future Planet backed Oxford Spinout, Offers Global Path to End of COVID-19
Future Planet Backed Oxford Spinout Offers Global Path to End COVID…
Future Planet backs Oxford’s Navenio
“Navenio exemplifies our investment thesis; best-in-class innovation from the world’s top university wrapped…